Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 6,476–6,500 of 7,816 matching trials · page 260 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Relative Bioavailability Study in Healthy Subjects to Evaluate the Pharmacokinetics of HTL0009936 After One Dose of Prototype Formulation NCT02710188 HTL0009936 modified release; HTL0009936 immediate release Runs in: United Kingdom · 1 site |
PHASE1 other |
COMPLETED | 14 | Nxera Pharma UK Limited INDUSTRY |
2016-10-18 |
|
The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation NCT02935998 Ziprasidone Runs in: China · 1 site |
PHASE4 other |
UNKNOWN | 1,000 | Yang Fude OTHER |
2016-10-18 |
|
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease NCT01928420 Drug: NIC5-15; Placebo Runs in: United States · 1 site |
PHASE2 other |
COMPLETED | 30 | Humanetics Corporation INDUSTRY |
2016-10-17 |
|
The Safety and Efficacy of Long-term Treatment of PINS Stimulator System for Patients With Alzheimer's Disease NCT02253043 Deep Brain Stimulation (Beijing PINS Medical Co., Ltd) Runs in: China · 2 sites |
NA other |
UNKNOWN | 10 | Beijing Pins Medical Co., Ltd INDUSTRY |
2016-10-14 |
|
PINS Stimulator System for Deep Brain Stimulation in Huntington's Disease NCT02263430 Deep Brain Stimulation |
NA other |
UNKNOWN | 8 | Beijing Pins Medical Co., Ltd INDUSTRY |
2016-10-14 |
|
A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease NCT00920946 Dimebon; Placebo Runs in: Australia; Canada; Denmark; Germany; Sweden; United Kingd... · 37 sites |
PHASE3 other |
COMPLETED | 403 | Medivation, Inc. INDUSTRY |
2016-10-12 |
|
An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease NCT01085266 Dimebon (latrepirdine) |
PHASE3 other |
TERMINATED | 362 | Medivation, Inc. INDUSTRY |
2016-10-12 |
|
Cytokines and Cognitive Decline in Alzheimer's Disease NCT01351142 blood test and cognitive tests Runs in: France · 10 sites |
NA other |
COMPLETED | 133 | Poitiers University Hospital OTHER |
2016-10-11 |
|
Working Memory Training in Huntington's Disease NCT02926820 Cogmed QM Runs in: Canada · 1 site |
NA other |
COMPLETED | 9 | York University OTHER |
2016-10-10 |
|
Comparison of Hand Feeding Techniques for Persons With Dementia NCT01780402 Hand feeding techniques Runs in: United States · 11 sites |
NA other |
COMPLETED | 30 | Duke University OTHER |
2016-10-06 |
|
The Study of Mechanism of Alzheimer's Disease Using Acupuncture Based on fMRI NCT02759159 true acupuncture; sham acupuncture Runs in: China · 2 sites |
NA other |
UNKNOWN | 120 | Xuanwu Hospital, Beijing OTHER |
2016-10-05 |
|
Effects of LEDs on Memory in TBI Patients NCT01598532 MedX Health Phototherapy (light therapy) Runs in: United States · 1 site |
NA other |
COMPLETED | 22 | Spaulding Rehabilitation Hospital OTHER |
2016-09-30 |
|
Dexmedetomidine and Intelligence Development in Pediatric Patients Undergoing Craniotomy NCT02810899 dexmedetomidine; normal saline Runs in: China · 1 site |
PHASE4 other |
COMPLETED | 60 | Peking University First Hospital OTHER |
2016-09-29 |
|
A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease NCT00675623 Dimebon; Dimebon; Placebo Runs in: United States · 28 sites |
PHASE3 other |
COMPLETED | 598 | Medivation, Inc. INDUSTRY |
2016-09-27 |
|
Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil NCT00829374 Dimebon; Dimebon; Placebo comparator Runs in: Australia; Belgium; Finland; France; Germany; Italy; New ... · 101 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 1,003 | Medivation, Inc. INDUSTRY |
2016-09-27 |
|
A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease NCT00954590 Dimebon (latrepirdine); Placebo Runs in: Chile; United Kingdom · 2 sites |
PHASE3 other |
TERMINATED | 89 | Medivation, Inc. INDUSTRY |
2016-09-27 |
|
An Extension of the CONCERT Protocol (DIM18) NCT01152216 Dimebon |
PHASE3 other |
TERMINATED | 672 | Medivation, Inc. INDUSTRY |
2016-09-27 |
|
Cognitive Intervention For Delirium in Dementia NCT01267682 Cognitive Stimulation Runs in: United States · 9 sites |
PHASE2 other |
COMPLETED | 283 | Penn State University OTHER |
2016-09-27 |
|
Treadmill Walking in Individuals With Dementia With Lewy Bodies and Huntington's Disease NCT02268617 Treadmill Walking Runs in: United States · 1 site |
NA other |
COMPLETED | 28 | Ohio State University OTHER |
2016-09-27 |
|
A Validation Study of the Novel Application of Telehealth in Clinical Drug Development in Subjects With Mild Cognitive Deficits NCT02778438 Runs in: United States · 1 site |
NA other |
COMPLETED | 30 | Quintiles, Inc. INDUSTRY |
2016-09-27 |
|
Evaluation of the Quality of Life in the Elderly With Dementia : Validation of a Specific Instrument NCT02814773 questionnaires Runs in: France · 1 site |
NA other |
COMPLETED | 310 | CHU de Reims OTHER |
2016-09-26 |
|
Gait and Alzheimer Interaction Tracking (GAIT) Study NCT01315717 Runs in: France · 1 site |
NA other |
COMPLETED | 912 | University Hospital, Angers OTHER_GOV |
2016-09-22 |
|
Alzheimer's Disease - Input of Vitamin D With mEmantine Assay NCT01409694 Memantine; Vitamin D; Vitamin D placebo Runs in: France · 1 site |
PHASE3 symptomatic-cholinergic |
COMPLETED | 90 | University Hospital, Angers OTHER_GOV |
2016-09-22 |
|
Comprehensive Care Transition: A Trial of an Enhanced Care Transition Process in Dementia NCT02415504 Enhanced care transition; Standard care transition Runs in: Canada · 1 site |
NA other |
TERMINATED | 29 | Baycrest OTHER |
2016-09-22 |
|
Support by Singing Sessions on Physical and Moral Pain : Assessment of Its Effectiveness in Alzheimer's Disease NCT02670993 Singing sessions.; Painting sessions. Runs in: France · 2 sites |
NA other |
COMPLETED | 59 | Centre Hospitalier Universitaire de Saint Etienne OTHER |
2016-09-20 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial